{'Year': '2019', 'Month': 'Feb'}
Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
The objective of this study was to study provider attitudes of and perceived barriers to the clinical use of pharmacogenomics before and during participation in an implementation program.